Welcome to our dedicated page for STANDARD MOTOR PRODUCTS SEC filings (Ticker: SMP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on STANDARD MOTOR PRODUCTS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into STANDARD MOTOR PRODUCTS's regulatory disclosures and financial reporting.
Standard Motor Products (SMP) filed a Form 144 notifying the proposed sale of 4,976 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $194,293.39. The shares are part of restricted stock that vested on 08/29/2025 and were recorded as compensation with the same acquisition and payment date. The filer indicated the approximate sale date as 09/03/2025. No other sales by the filer in the past three months were reported. The filer certifies they are not aware of undisclosed material adverse information about the issuer.
Standard Motor Products (SMP) posted strong top- and bottom-line growth in its Q2 2025 10-Q. Net sales jumped 27% YoY to $493.9 million, boosted by the first full-quarter inclusion of the November 2024 Nissens Automotive acquisition and solid gains across Vehicle Control (+7%) and Temperature Control (+6%). Gross profit rose 35% to $150.9 million, expanding margin 200 bp to 30.6% as mix and scale offset higher supply-chain finance costs.
Operating income climbed 71% to $42.8 million (8.7% margin), while diluted EPS from continuing operations increased 44% to $1.17. Six-month diluted EPS totaled $1.69, up 46%. Cash flow from operations was a modest use of $5.9 million, an improvement on the prior-year $10.1 million outflow, but working-capital needs remain elevated (inventories $638.6 million; receivables $327.3 million).
Debt rose to $636.6 million (vs. $562.3 million at 12/31/24) to fund the Nissens deal, pushing quarterly interest expense to $8.3 million (+202% YoY). Leverage is largely floating-rate (avg. 5.0%) and matures mainly in 2029. Shareholders’ equity increased 12% to $703.5 million, helped by a $42.7 million FX-translation gain. The company declared a $0.31 quarterly dividend (2% YoY increase).
Key watch-points: integration of Nissens, execution of ongoing restructuring/cost-reduction programs (remaining liability $2.1 million), negative operating cash flow, and asbestos liability of $75.4 million.